Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2

Publication Type:
Journal Article
Citation:
ACS Chemical Neuroscience, 2017, 8 (9), pp. 1949 - 1959
Issue Date:
2017-09-20
Metrics:
Full metadata record
Files in This Item:
Filename Description Size
0C62479F-8877-49E1-AA80-4291C5B7953E am.pdfAccepted Manuscript Version781.87 kB
Adobe PDF
© 2017 American Chemical Society. It has been demonstrated previously that the endogenous compound N-arachidonyl-glycine inhibits the glycine transporter GlyT2, stimulates glycinergic neurotransmission, and provides analgesia in animal models of neuropathic and inflammatory pain. However, it is a relatively weak inhibitor with an IC50 of 9 μM and is subject to oxidation via cyclooxygenase, limiting its therapeutic value. In this paper we describe the synthesis and testing of a novel series of monounsaturated C18 and C16 acyl-glycine molecules as inhibitors of the glycine transporter GlyT2. We demonstrate that they are up to 28 fold more potent that N-arachidonyl-glycine with no activity at the closely related GlyT1 transporter at concentrations up to 30 μM. This novel class of compounds show considerable promise as a first generation of GlyT2 transport inhibitors.
Please use this identifier to cite or link to this item: